ArticleBMC medical informatics and decision making2026
AMIUgraph: analysis and modeling of interactions for utility-driven benchmarking of graph-based models in healthcare.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGraph-based machine learning approaches, including Knowledge Graph Embedding (KGE) methods and Graph Neural Networks (GNNs), have emerged as powerful tools for modeling complex biomedical data. However, a systematic and clinically grounded comparison of these approaches across heterogeneous healthcare graphs, accounting for both predictive performance and real-world deployment constraints, is still lacking.
methodsWe introduce AMIUGraph, a comprehensive benchmarking framework for healthcare link prediction that integrates real-world clinical data with external biomedical knowledge bases. AMIUGraph evaluates eight state-of-the-art models, of which four are knowledge graph embedding (KGE) methods DistMult, CP, ComplEx, and ConvE and four are graph neural network (GNN) architectures GCN, GraphSAGE, GAT, and GIN. The models are evaluated across three heterogeneous bipartite graphs representing Patients-Diseases, Diseases-Drugs, and Drugs-Targets interactions. Models are assessed under both transductive and inductive learning settings using accuracy, AUC, precision, recall, F1-score, and training time as evaluation metrics.
resultsExperimental results show that model performance is strongly influenced by graph structure and sparsity. GNNs consistently achieve superior predictive performance on sparse interaction graphs, particularly for Diseases-Drugs and Drugs-Targets prediction tasks. In contrast, KGE models demonstrate competitive accuracy with substantially lower computational costs in inductive clinical scenarios involving unseen patients. These trends are especially relevant in clinically realistic settings characterized by multimorbidity, such as gastrointestinal and liver diseases, where frequent patient updates and complex therapeutic interactions are common.
conclusionAMIUGraph provides a clinically grounded and utility-driven benchmarking framework that jointly evaluates KGE and GNN models across multiple healthcare graph types and learning settings. The findings offer practical guidance for selecting graph-based models in medical decision-support systems, including applications in gastrointestinal healthcare, while promoting transparency and reproducibility through the public release of all datasets, protocols, and code.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.